Delgocitinib (Anzupgo)
To treat moderate-to-severe chronic hand eczema when topical corticosteroids are not advisable or produce an inadequate response
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
To treat moderate-to-severe chronic hand eczema when topical corticosteroids are not advisable or produce an inadequate response